Volpara Health Technologies
Financials
Estimates*
AUD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 12.3m | 18.1m | 24.3m | 32.8m | 41.4m | 49.1m | 55.2m |
% growth | 146 % | 47 % | 34 % | 35 % | 26 % | 19 % | 12 % |
EBITDA | (19.5m) | (14.4m) | (10.6m) | (5.2m) | (<1m) | 4.2m | 12.3m |
% EBITDA margin | (158 %) | (80 %) | (43 %) | (16 %) | (2 %) | 9 % | 22 % |
Profit | (19.8m) | (16.1m) | (15.3m) | (9.2m) | (5.5m) | (<1m) | 8.0m |
% profit margin | (161 %) | (89 %) | (63 %) | (28 %) | (13 %) | (1 %) | 14 % |
EV / revenue | 16.9x | 16.6x | 8.6x | 5.6x | 6.9x | 5.7x | 4.8x |
EV / EBITDA | -10.7x | -20.9x | -19.7x | -35.5x | -336.9x | 65.8x | 21.4x |
R&D budget | 10.6m | 13.0m | 15.7m | 16.5m | - | - | - |
R&D % of revenue | 86 % | 72 % | 64 % | 50 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $5.5m | Early VC | |
N/A | $10.0m Valuation: $61.0m | IPO | |
N/A | N/A | Early VC | |
N/A | N/A | Early VC | |
* | $193m Valuation: $193m 12.3x EV/LTM Revenues -28.3x EV/LTM EBITDA | Acquisition | |
Total Funding | €5.0m |
Related Content
Recent News about Volpara Health Technologies
EditVolpara Health is a healthcare technology company specializing in breast health, leveraging artificial intelligence (AI) to enhance early detection of breast cancer. The company operates in the medical imaging and healthcare analytics market, serving breast imaging centers and healthcare providers globally. Volpara's core product is its Breast Health Platform, which integrates AI for clinical decision support, personalized detection strategies, and optimized program performance. This platform is clinically validated and trusted by top cancer screening centers, improving mammogram quality and reducing false positives. Volpara generates revenue through a subscription-based business model, offering its software as a service (SaaS) to healthcare facilities. The company aims to revolutionize breast cancer screening and care, ensuring better outcomes for patients through advanced technology and personalized care.
Keywords: AI, breast health, early detection, cancer screening, healthcare analytics, mammogram quality, clinical decision support, personalized care, SaaS, medical imaging.